Polycythemia, SGLT2 inhibitors, and associated outcomes across the cardio-kidney-metabolic spectrum: a pooled analysis of randomized trials

Citation:

Marques P, Vasques-Nóvoa F, Pintalhão M, et al. Eur J Intern Med. 2026 Jun 8:106989. Epub ahead of print. PMID: 42259701.